Interferon-α-induced psoriasis;INTERFERON-α-INDUZIERTE PSORIASIS VULGARIS

Hautarzt

Volumn 47, Issue 2, 1996, Pages 124-128

  Wolfer L U ^b   Goerdt, S ^a,b   Schroder K ^b   Zouboulis, Ch C ^b   Orfanos, C E ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

interferon ; psoriasis vulgaris

Indexed keywords

ALPHA INTERFERON; CALCIPOTRIOL; DITHRANOL; ETRETIN; ETRETINATE; INTERLEUKIN 2; PREDNISOLONE; TRIAMCINOLONE;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; HEPATITIS C; HUMAN; KAPOSI SARCOMA; KIDNEY CARCINOMA; MALE; PSORIASIS VULGARIS; TOPICAL DRUG ADMINISTRATION;

ADULT; CARCINOMA, RENAL CELL; HEPATITIS C; HIV INFECTIONS; HUMANS; INFUSIONS, INTRAVENOUS; INTERFERON-ALPHA; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PSORIASIS; SARCOMA, KAPOSI; SKIN NEOPLASMS;

EID: 0029924235     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050388     Document Type: Article

References (29)

1. Barna M, Snijdewint FGM, van der Heijden FL, Bos JD, Kapsenberg ML (1994) Characterization of lesional psoriatic skin T lymphocyte clones. Acta Derm Venereol (Stockh) [Suppl] 186: 9-11
2. Beyaert R, Schulze-Osthoff K, Van Roy F, Fiers W (1992) Synergistic induction of interleukin-6 by tumor necrosis factor and lithium chloride in mice: possible role in the triggering and exacerbation of psoriasis by lithium treatment. Eur J Immunol 22: 2181-2184
3. Bjerke JR, Livden JK, Degre M, Matre R (1983) Interferon in suction blister fluid from psoriatic lesions. Br J Dermatol 108: 295-299
4. Creaven PJ, Stoll HL (1991) Response to tumor necrosis factor in two cases of psoriasis. J Am Acad Dermatol 24. 735-737
5. DiGiovanna JJ, Toombs EL, Peck JL (1988) Gamma-interferon therapy of psoriasis. J Invest Dermatol 90: 554
6. Fierlbeck G, Rassner G, Müller C (1990) Psoriasis induced at the injection site of recombinant interferon-gamma. Arch Dermatol 126: 351-355
7. Funk F, Langeland T, Schrumpf E, Hanssen LE (1991) Psoriasis induced by interferon-alpha. Br J Dermatol 125: 463-465
8. Garcia-Lora E, Tercedor J, Massare E, Lopez-Nevot MA, Skiljo M, Garcia-Mellado V (1993) Interferon-induced psoriasis in a patient with chronic hepatitis C. Dermatology 187: 280
9. Georgetson Mj, Yarze JC, Lalos AT, Webster GF, Martin P (1993) Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis. Am J Gastroenterol 88: 1756-1758
10. Harrison PV, Peat M (1986) Effect of interferon on psoriasis. Lancet II: 457-458
11. Harrison P (1989) Exacerbation of psoriasis with alpha-interferon. J Invest Dermatol 93: 355
12. Hartmann F, von Wussow P, Deicher H (1989) Psoriasis-Exazerbation bei Therapie mit alpha-Interferon. DMW 114: 96-98
13. Jucgla A, Macrcoval J, Curro N, Servitje O (1991) Psoriasis with articular involvement induced by interferon alpha. Arch Dermatol 127: 910-911
14. Kapp A (1993) Die Rolle von Zytokinen fur die Pathogenese der Psoriasis. Hautarzt 44: 201-207
15. Kelly RI, Marsden RA, Bevan D (1993) Exacerbation of psoriasis with GM-CSF therapy Br J Dermatol 128: 468-469
16. Kelly RI, Marsden RA (1994) Granulocyte-macrophage colony-stimulating factor and psoriasis. J Am Acad Dermatol 30: 144-145
17. Kusee R, Ostojic S, Planinc-Peraica A. Minigo H, Jacsic B (1990) Exacerbation of psoriasis after treatment with alpha-interferon. Dermatologica 181: 170
18. Lee RE, Gaspari AA, Lotze MT, Chang AE. Rosenberg SA (1988) Interleukin-2 and psoriasis. Arch Dermatol 124: 1811-1815
19. Neumann R, Pohl-Markl H, Aberer E (1987) Parenteral interferon-alpha treatment of psoriasis. Dermatologica 175: 23-28
20. Nickoloff BJ (1991) The cytokine network in psoriasis. Arch Dermatol 127: 871-884
21. Pauluzzi P, Kokelj F, Perkan V, Pozzato G, Moretti M (1993) Psoriasis exacerbation induced by interferon-alpha. Report of two cases. Acta Derm Venerol (Stockh) 73: 395
22. Prinz JC, Groß B, Vollmer S, Trommler P, Strobel I, Meurer M, Plewig G (1994) T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products. Eur J Immunol 24: 593-598
23. Quesada JR, Gutterman JU (1986) Psoriasis and alpha-interferon. Lancet 1: 1486-1488
24. Raychaudhuri SP, Fiore MM (1992) Clearance for unremitting psoriasis after treatment with granulocyte-macrophage colony-stimulating factor. J Am Acad Dermatol 27: 451-452
25. Schlaak JF, Buslau M, Jochum W, Hermann E, Girndt M, Gallati H, Meyer zum Büschenfelde KH, Fleischer B (1994) T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 102: 145-149
26. Shiohara T, Kobayashi M, Abe K, Nagashima M (1988) Psoriasis occurring predominantly on warts. Arch Dermatol 124: 1816-1821
27. Takematsu H, Olzawa H, Yoshimura T, Hara M, Sakakibara A, Oyama J, Tagami H (1991) Systemic TNF administration in psoriatic patients: a promising therapeutic modality for severe psoriasis. J Am Acad Dermatol 24: 735-737
28. Tomfohrde J, Silverman A, Barnes R, Fernandez-Vina MA, Young M, Lory D, Morris L, Wuepper KD, Stasny P, Menter A, Bowcock A (1994) Gene for familial psoriasis susceptibility mapped for the distal end of human chromosome 17q. Science 264: 1141-1145
29. Voorhees JJ, Marcelo CL, Duell EA (1975) Cyclic AMP, cyclic GMP and glucocorticoids as potential metabolic regulators of epidermal proliferation and differentiation. J Invest Dermatol 65: 179-180